Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subscapularis pyomyositis, a rare cause of shoulder pain, in a patient without apparent risk factors: A case report.

International journal of surgery case reports·2024
Same author

Necrotizing Fasciitis of the Thigh and Calf: A Reminder to Exclude a Perforated Intra-Abdominal Viscus: A Case Report.

JBJS case connector·2017
Same author

Validation of a modified FRAX® tool for improving outpatient efficiency--part of the "Catch Before a Fall" initiative.

Archives of osteoporosis·2015
Same author

Coordination patterns of shoulder muscles during level-ground and incline wheelchair propulsion.

Journal of rehabilitation research and development·2013
Same author

Patterns of shoulder muscle coordination vary between wheelchair propulsion techniques.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2013
Same author

Effect of velocity on shoulder muscle recruitment patterns during wheelchair propulsion in nondisabled individuals: pilot study.

Journal of rehabilitation research and development·2013

Related Experiment Video

Updated: May 29, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

Tissue Engineering Stem Cells - An e-Governance Strategy.

Simon Grange1

  • 1Alberta Bone and Joint Health Institute, McCaig Institute, University of Calgary, Canada.

The Open Orthopaedics Journal
|September 3, 2011
PubMed
Summary

Evolving governance rules enhance subject protection in novel therapeutic vector research. Advanced Therapeutic Medicinal Products (ATMP) require robust Virtual Research Integration and Collaboration (VRIC) systems for regulatory compliance and tissue handling.

Keywords:
Cell therapiesgovernanceinterventionregulationsresearchtissue engineering.

More Related Videos

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
09:24

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Engineering a Bilayered Hydrogel to Control ASC Differentiation
07:48

Engineering a Bilayered Hydrogel to Control ASC Differentiation

Published on: May 25, 2012

Related Experiment Videos

Last Updated: May 29, 2026

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
09:24

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Engineering a Bilayered Hydrogel to Control ASC Differentiation
07:48

Engineering a Bilayered Hydrogel to Control ASC Differentiation

Published on: May 25, 2012

Area of Science:

  • Biomedical research
  • Health policy
  • Regenerative medicine

Background:

  • Increasingly stringent governance is necessary due to unpredictable side effects of novel therapeutic vectors.
  • Existing evidence supports e-Governance in health research and policy formation.
  • The UK Comprehensive Research Network and EU Directives have influenced current regulatory frameworks.

Purpose of the Study:

  • To review the regulatory framework for cell therapies in musculoskeletal science, focusing on Advanced Therapeutic Medicinal Products (ATMP).
  • To highlight the need for enhanced Virtual Research Integration and Collaboration (VRIC) systems for regulatory compliance.
  • To outline strategies for technology research and development in association with tissue engineering and clinical practice.

Main Methods:

  • Review of existing evidence on e-Governance in health research.
  • Analysis of the impact of UK Comprehensive Research Network and EU Directives.
  • Examination of regulatory frameworks for Advanced Therapeutic Medicinal Products (ATMP).

Main Results:

  • The development of the ATMP category necessitates a focus on regulation for cell therapies.
  • There is a clear need for more detailed VRIC systems to ensure regulatory compliance.
  • Technology R&D must closely align tissue engineering with treating clinicians.

Conclusions:

  • Effective governance requires stringent regulations for novel therapies, particularly cell therapies in musculoskeletal science.
  • Advanced Virtual Research Integration and Collaboration (VRIC) systems are crucial for navigating ATMP regulations.
  • Compliance with EU directives and Human Tissue Authority (HTA) regulations is essential for handling human tissues, transport, and specimen storage.